T Cell Dysfunction in Cancer.


Therapeutic reinvigoration of tumor-specific T cells has greatly improved clinical outcome in cancer. Nevertheless, many patients still do not achieve durable benefit. Recent evidence from studies in murine and human cancer suggest that intratumoral T cells display a broad spectrum of (dys-)functional states, shaped by the multifaceted suppressive signals that occur within the tumor microenvironment. Here we discuss the current understanding of T cell dysfunction in cancer, the value of novel technologies to dissect such dysfunction at the single cell level, and how our emerging understanding of T cell dysfunction may be utilized to develop personalized strategies to restore antitumor immunity.

More about this publication

Cancer cell
  • Volume 33
  • Issue nr. 4
  • Pages 547-562
  • Publication date 09-04-2018

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.